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Background: Breast cancer is one of the most common types of cancers affecting women worldwide. The main
objective of this study was to assess and compare research activity in breast cancer in Arab countries with non-Arab
Middle Eastern countries.
Methods: Publications about “breast cancer” as a research topic were retrieved using the ISI Web of Science database.
Analysis was confined to original research and review articles. Research productivity was assessed by assessing number
of publications and time trend of these publications, names of journals, citation analysis, top 10 active institutions as
well as country contribution to breast cancer research. The quantity and quality of publications from Arab countries in
addition to 3 other Middle East countries (Turkey, Iran and Israel) were assessed and compared using the h-index tool.
Results: A total of 1658 original research and review articles about “breast cancer” were published from Arab countries.
Annual research productivity from Arab countries in the field of “breast cancer” was negligible but showed a significant
increase in the last decade. Retrieved documents had relatively high citation parameters as measured by h-index of 61
and average citations of 17.46 per document. The highest research productivity was from Egypt with a total publication
of 582 (35.10%). Cairo University with a total of 149 (8.99%) publications had the highest research productivity among
institutions in Arab world. Forty four documents (2.65%) of breast cancer documents were published in Saudi Medical
Journal. Arab researchers collaborated mostly with researchers from the United States of America (305; 18.40%) in breast
cancer research. Compared with other non-Arab Middle Eastern countries, Arab countries had higher research
productivity than some countries and lower than others, particularly Israel.
Conclusions: The present data reveals a good contribution of some Arab countries to the field of “breast cancer”
research. There is a gap between Arab countries and Israel in the quality of breast cancer research.
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Breast cancer is one of the most common types of can-
cers among women in the Arab world [1]. Research in
general and in breast cancer in particular is important
for each country in order to understand the cultural and
genetic differences among different people in different
geographical areas. Therefore, assessing research about
breast cancer from Arab countries has an important
impact on the future policies in the fight against such an* Correspondence: waleedsweileh@yahoo.com
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unless otherwise stated.emotionally disturbing type of cancer. In addition, no
doubt that high research activity in breast cancer can
reflect positively on screening programs, awareness,
epidemiological data and clinical practice. Assessing re-
search activity in any subject in any geographical region
is not an easy task given the diversity of academic data-
bases and indexing methods of such databases. One of
the most commonly utilized methods to assess research
activity is known as bibliometric methods which have
been applied to various medical subjects in different
countries [2-8]. No doubt that the Arab world have wit-
nessed great progress in the past few decades in medical
education and medical practice including establishingl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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leges. Furthermore, many governments in the Arab
world, particularly in the Arab Gulf, have financially en-
dorsed the development of medical research and practice
to serve the general public health of their people. The
Arab world has an overall population of around 380 mil-
lion and extends over a large geographical area in north-
ern Africa and Middle East. Our research group have
previously published several bibliometric studies in dif-
ferent medical disciplines like osteoporosis, diabetes,
toxicology and others [9-11]. In this study, our research
group is trying to shed light on a very important health
topic pertaining to women’s health and public health as
well which is breast cancer research activity in Arab
countries. The objective of this study was to assess pub-
lication trend in Arab countries in breast cancer and
compare it with non-Arab Middle Eastern countries.
Such study will give an insight into research activity and
will encourage those in the field of breast cancer.
Methods
The methodology as well as the tool used in this study
were discussed in previous publications by the same
group [11,12]. The tool used was ISI Web of Science
(WoS) [13]. The method used in this study is similar to
the method used by the authors in their previous publi-
cations [11,14,15]. For the purpose of this study, WoS is
preferred over PubMed because PubMed does not allow
for citation analysis. Similarly, WoS is preferred over
Scopus because WoS includes the most influential and
prestigious journals in all medical fields. All Arab coun-
tries were used as country keys followed by “breast can-
cer” phrase as a topic. We focused on the phrase “breast
cancer” as search topic (TS) and excluded any other as-
sociated phrases like “mammary ducts” because we are
interested in breast cancer per se rather than associated
cancers. Because the WoS database does not recognize
Palestine as an independent state yet, search for breast
cancer documents from Palestine was carried out using
separate search keys. The results from 21 Arab countries
and those from Palestine were combined and the result-
ant data were analyzed. Only original research articles
and review articles were included in the analysis. Fur-
thermore, analysis was made up to year 2012 while 2013
and 2014 years were excluded because they are still open
for new journal issues. The standard competition ranking
(SCR) was used to present the top 10 ranking data while
journal’s impact factors (IF) were evaluated using the
Journal Citation Report (JCR; Web of Science) 2013 sci-
ence edition by Thomson Reuters (New York, NY, USA).
Results
The total number of worldwide publications in breast can-
cer retrieved from Arab countries was 1658 publicationswhile worldwide number was 206,710. Therefore, “breast
cancer” research output from Arab countries represents
0.8% of the global research productivity in “breast cancer”.
The first article about breast cancer co-authored by an
Arab researcher was published in 1977 in Cancer Journal
and the title of the article was: “Clinical and prognostic fea-
tures of a rapidly progressing breast-cancer in Tunisia”.
The annual number of publications from Arab coun-
tries indicated that “breast cancer” research output
remained low until mid-1990s and showed a significant
increase in the last three years. Approximately 50% of
breast cancer documents from Arab countries were pub-
lished in 2010, 2011 and 2012. Figure 1 shows the an-
nual growth of breast cancer research documents from
Arab countries. When retrieved data were analyzed
by country, Egypt (582; 35.10%) had the highest re-
search output followed by Kingdom of Saudi Arabia
(372; 22.44%) and Tunisia (172; 10.37%). No data related
to breast cancer was found from Somalia, Djibouti,
Mauritania and Comoros (Table 1). The language of most
breast cancer documents published from Arab countries
was English (1589; 95.84%) while the remaining docu-
ments were published in French language (69; 4.16%).
One hundred and ninety three (11.64%) documents were
open access while the remaining (88.36%) were not open
access. Countries whose researchers collaborated most in
breast cancer research with investigators in the Arab
world include the United States of America (USA); (305;
18.40%) followed by France (139; 8.38%) and England
(132; 7.96%).
The total number of citations for breast cancer docu-
ments from the Arab world, at the time of data analysis,
was 28,953 with an average citation of 17.46 per
document. Of the 1658 documents considered for
the h-index, 61 had been cited at least 61 times at
the time of data analysis. When stratified by country, the h
index was highest for breast cancer documents published
from Egypt (h-index = 43) followed by those published
from KSA (h-index =31) and Tunisia (h-index =26). Of the
1658 breast cancer documents published from Arab
countries, there were 660 (39.81%) documents in the
oncology research area, 185 (11.16%) in the pharmacology/
pharmacy research areas, and 128 (7.72%) documents in
Biochemistry/Molecular Biology. Other research areas
found in published documents from the Arab countries
are shown in Table 2.
Table 3 lists the top 10 journals in which documents
in breast cancer were published from Arab countries.
Forty four (2.65%) breast cancer documents from Arab
countries were published in Saudi Medical Journal
which is a non-oncology journal. Of the top 10 journals
in which breast cancer documents were published from
the Arab countries, only 1 journal (International Journal
of cancer Research) had an impact factor > 5. Table 4
Figure 1 Annual growth of breast cancer research output from Arab countries, Turkey, Israel and Iran. Earlier data were not shown in the
figure because it is almost approaching zero for most Arab countries.
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breast cancer. The most productive institution was Cairo
University (149; 8.99%) followed by King Saud University
(117; 7.06%). Eight institutions in the top 10 list are
academic institutions affiliated with teaching hospitals
that have oncology departments.
Compared with other non-Arab countries in the
Middle East, the research productivity from the Arab
countries was lesser than that from Israel and Turkey
but higher than that from Iran (Figure 1). The h index of
breast cancer documents published from Arab countries
was higher than that of Turkey and Iran but was much
lower than that from Israel. The journal with the highest
number of breast cancer documents published from
Arab countries was Saudi Medical Journal (IF of 0.55);
that from Turkey and Iran was Asian Pacific Journal of
Cancer Prevention (IF = 1.50), while that from Israel was
Journal of Cancer Research (IF = 9.28); (Table 5). The an-
nual growth of breast cancer research output from Arab
countries, Israel, Turkey and Iran is shown in Figure 1.
Breast cancer research in Israel started as early as 1973
and showed a continuous momentum since then. How-
ever, breast cancer research in Arab countries, Turkey
and Iran started breast cancer research after 1977 and
showed great fluctuations up until mid-1990s. Regarding
research interests, biochemistry/ genetics and cell biol-
ogy constituted approximately 25% of breast cancerdocuments from Israel but less than 10% in Arab coun-
tries or Turkey or Iran. Finally, it should be noted that
of the documents published from Israel, there were 16
documents about breast cancer in Israeli Arab women,
either in comparison with Jewish women or being inves-
tigated as a separate cultural group.
Discussion
In this study, we assessed the research activity about
breast cancer from Arab countries. We used the ISI web
of science database as a method to assess research activ-
ity. Up to the author’s best knowledge, this is the first
bibliometric study to assess breast cancer research activ-
ity from Arab world. Bibliometric studies that assessed
global breast cancer research productivity has been pre-
viously published but with no detailed emphasis on Arab
region [16,17].
The result indicated that 1658 documents in breast
cancer were published from Arab countries up to year
2012. This number is an important piece of information
for future analysis and for health policy makers. It
should be emphasized that some journals in which Arab
researchers have published about breast cancer are not
indexed in ISI web of science. For example, articles per-
taining to breast cancer that were published in Journal
of the Egyptian National Cancer Institute or Eastern
Mediterranean Health Journal were not considered in
Table 1 Contribution of each Arab country to the 1658
breast cancer published documents
Country Number of documents
N (%) = 1658 (100%)*
h index
Egypt 582 (35.10) 43
Kingdom of Saudi Arabia 372 (22.44) 31
Tunisia 172 (10.37) 26
Kuwait 121 (7.30) 21
Lebanon 120 (7.24) 23
United Arab Emirates 89 (5.37) 22
Jordan 79 (4.76) 18
Morocco 73 (4.40) 15
Qatar 32 (1.93) 11
Algeria 27 (1.63) 9
Sudan 21 (1.28) 6
Iraq 21 (1.28) 7
Libya 20 (1.21) 6
Syria 18 (1.09) 8
Yemen 17 (1.03) 7
Oman 13 (0.78) 7
Palestine 10 (0.52) 6
Bahrain 7 (0.42) 3
Somalia 0 (0.0) 0
Comoros 0 (0.0) 0
Djibouti 0 (0.0) 0
Mauritania 0 (0.0) 0
*total exceeds 100% because of overlap in some documents among more
than one Arab country.
Table 2 Research areas of the 1658 breast cancer
documents published from the 22 Arab countries
SCRa Research area Number (%)
N = 1658 (100%)
1st Oncology 660 (39.81)
2nd Pharmacology Pharmacy 185 (11.16)
3rd Biochemistry Molecular Biology 128 (7.72)
4th Pathology 103 (6.21)
5th General Internal Medicine 101 (6.09)
6th Chemistry 94 (5.67)
6th Obstetrics Gynecology 94 (5.67)
8th Cell Biology 89 (5.37)
9th Radiology Nuclear Medicine Medical Imaging 74 (5.49)
10th Surgery 54 (3.26)
Abbreviation: SCR = Standard Competition Ranking.
aEqual research areas have the same ranking number, and then a gap is left in
the ranking numbers.
Table 3 Top 10 journals in which breast cancer
documents from the 22 Arab countries were published
SCRa Journal Number (%)
N = 1456
IFb
1st Saudi Medical Journal 44 (2.65) 0.554
2nd Asian Pacific Journal of Cancer Prevention 41 (2.47) 1.50
2nd Breast Cancer Research and Treatment 41 (2.47) 4.19
4th Anticancer Research 38 (2.29) 1.872
5th Breast 25 (1.51) 2.581
6th European Journal of Medicinal Chemistry 24 (1.45) 3.432
6th Medical Oncology 24 (1.45) 2.058
9th Life Science Journal Acta Zhengzhou
University Overseas Edition
22 (1.33) 0.165
10th Cancer 20 (1.21) 4.901
10th International Journal of Cancer 20 (1.21) 5.007
Abbreviations: SCR = Standard Competition Ranking; NA = not available;
IF = impact factor.
aEqual journals have the same ranking number, and then a gap is left in the
ranking numbers.
bThe impact factor was reported according to Institute for Scientific
Information (ISI) journal citation reports (JCR) 2012.
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WoS. Therefore, the result obtained might be lesser than
the actual research activity in Arab countries. Despite
that, our study reflects a close approximation of breast
cancer research activity in the Arab world and that is
present in international and reputable journals. The ISI
of Web of Science gives a powerful and attractive cit-
ation analysis for bibliometric studies. Furthermore, the
ISI Web of Science database reflects publications in
journals which have scientific and international impact
as well as large audience and readers in the field of breast
cancer.Table 4 Top 10 active institutions in breast cancer
research in Arab countries
SCR Institution Number (%)
N = 1658
Country
1st Cairo University 149 (8.99) Egypt
2nd King Saud University 117 (7.06) KSA
3rd King Faisal Specialist Hospital
Research Center
115 (6.94) KSA
4th Kuwait University 104 (6.27) Kuwait
5th American University of Beirut 83 (5.01) Lebanon
6th Alexandria University 56 (3.38) Egypt
7th Mansoura University 53 (3.20) Egypt
8th Ain Shams University 47 (2.84) Egypt
9th Assiut University 46 (2.97) Egypt
10th National Research Center 45 (2.71) Egypt
Abbreviations: SCR = Standard Competition Ranking; KSA = Kingdom of
Saudi Arabia.
Table 5 Breast cancer research output from Arab countries compared with that from Turkey, Israel, and Iran
Data/Country 22 Arab countries Turkey Israel Iran
Number of population in millions 380 60 8 80
Number of published research
articles and review articles
1658 2025 2440 731
Total number of citations 28,953 22,438 96,323 7807
Average citation per document 17.46 11.08 39.48 10.68
h-index 61 56 128 37
Country with the highest
collaboration (%)
USA 18.40% USA 8.64% USA 26.11% USA 6.98%
Journal with the highest
publication (N); (IF)
Saudi Medical Journal (44)
IF = 0.554
Asian Pacific Journal of Cancer
Prevention (78) IF = 1.50
Cancer Research (87)
IF = 9.28
Asian Pacific Journal of Cancer
Prevention (64) IF = 1.50
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ing types of cancers for women all over the world. One
of the best methods to combat breast cancer and im-
prove the quality of life of women in Arab world is to do
breast cancer screening surveys. Unfortunately, it has
been reported that breast cancer screening participation
rates are low among women in the Arab world [18]. Ef-
forts to combat breast cancer at the global and regional
levels should be collective and all those in field need to
contribute in this fight against breast cancer at all levels.
Research is an important aspect and contribution that
can help in combating breast cancer globally and at
the regional level. The importance of regional research
about breast cancer stems from the fact that cultural
and genetic variations might affect breast cancer dis-
ease profile among women in different regions and
countries.
Our results showed that breast cancer research was
neglected in most Arab countries during the 1970s and
1980s. Despite the valuable contribution of Arabs to
medicine throughout history [19], reports indicated that
medical research activity in Arab world is still lagging
behind compared to non-Arab countries in the region
like Israel, Turkey or Iran [9,20-24]. Until the time of
writing this manuscript, breast cancer research activity is
considered low in many Arab countries including those
with good economy like Bahrain. On the other hand,
breast cancer research in Egypt and KSA showed a steep
rise in the past decade. Actually, some of the research
activity in Egypt and KSA was governmentally funded
suggesting a national policy to promote cancer research
as one preventive strategy to combat this devastating
type of cancer. Our findings regarding research activity
from Egypt and KSA might not be surprising given that
previous research indicated that Egypt and KSA have
high biomedical research output [24,25]. Low research
activity in some Arab countries is a multi-faceted prob-
lem that could be attributed at least in part to, inadequate
research infra- structure in many cancer institutions inthese countries, the modest governmental and non-
governmental funding, in addition to a poor cooper-
ation between industry and academia. Governments
in the Arab world need to consider these factors if
they wish to improve the status of their scientific re-
search [24,26-28].
Our study indicated that the average citation per
breast cancer document from Arab world was 17.46.
This is relatively a high number and suggests that there
is a growing interest in breast cancer from the Arab
world and that competition in this field is growing
as well. Highly cited articles positively contribute to the
h-index of the individual author and to the institution
and country [29-32]. The citation is a key indicator of
research quality [33]. The h-index simultaneously meas-
ure the quality and quantity of scientific output. How-
ever, h-index measured using different databases can
give different values and therefore each database has
pros and cons when measuring the h-index [34-36]. Crit-
icisms have also been addressed to the use of h-index as a
marker of publication quality and citation. For example,
the h-index does not consider the context of citations, the
number of authors in the document, and gives equal
values for book citation and research citation. Therefore,
the h-index has lesser predictive accuracy and preci-
sion than mean citations per paper, although this is
controversial [37,38].
In our study, the h-index of breast cancer docu-
ments published from Israel was higher than that for
breast cancer documents published from Arab coun-
tries or Iran or Turkey. One possible reason for this is
the impact factor of journals in which Israeli re-
searchers publish their breast cancer research. Israeli
researchers with high quality research tend to publish
their research in high impact factor journals like Cancer
Research Journal. Such publications in high impact jour-
nals might have increased the citations for Israeli publi-
cations in the field of breast cancer [39,40]. When
submitting a manuscript for publications, authors are
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cation free, follow open access policy, preferably have
a high impact factor, and above all have a short edi-
torial and revision time [41,42]. Researchers from
Arab world have preferred publishing breast cancer
research in Saudi medical Journal. This medical jour-
nal poses no publication fee and represents an open
forum for medical research discussions in the Arab
world.
Our results showed that authors from Arab and non-
Arab countries like Israel, Turkey and Iran collaborated
mainly with authors from the USA in breast cancer re-
search. International collaboration is beveled to increase
the quantity and quality of research activity [43-45].
Breast cancer research in Israel was evidently better than
that from Arab countries in quantitative and qualitative
terms. One possible reason for this is the intensive
collaboration between Israeli and the USA researchers in
the field of breast cancer. One explanation for this inten-
sive collaboration between Israeli and the USA re-
searchers is the fact that the status of cancer research in
Israel is parallel to that in the USA. Collaboration in re-
search activity can increase the visibility, quantity and
quality of research output from any particular country
or institution [46-50].
Our study has points of strength and points of weak-
nesses. This is the first study in the Arab world to inves-
tigate and assess breast cancer research activity. The
study showed that only few Arab countries, particularly
Egypt and KSA had good research output in breast can-
cer while other Arab countries had limited research
activity in this field. Of course, this study does not mean
to negatively criticize research activity in any particular
country, rather it meant to draw attention and encour-
age researchers in this field. Finally, it should be men-
tioned that our study has few limitations which are
the same as those of previously published bibliometric
studies [51-53].
Conclusion
The present data reveals a good late momentum for
breast cancer research activity from the Arab world.
However, the quantity and quality of breast cancer re-
search was low for some Arab countries. Governmental
funding and survey programs are important to increase
the volume of data available for research in Arab coun-
tries. No doubt that researchers in Arab countries need
to invest more in the molecular biology and genetics of
breast cancer among Arab in order to bridge the gap in
this field of research with Israeli researchers. Higher
education institutions and research centers in Arab
countries should build new bridges of collaboration with
their international counterparts to promote breast can-
cer research in Arab countries.Abbreviations
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